Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Ralaniten triacetate | 1637573-04-6 | 98.8% | 521.00 g/mol | C27H33ClO8 | 10MG
SDP

Supplier:  Medchemexpress LLC HY123875A10MG

Encompass_Preferred

Ralaniten triacetate is an orally active prodrug that targets the androgen receptor N-terminal domain (AR-NTD) and is provided for non-clinical research into AR-driven prostate cancer mechanisms. Manufacturer data include analytical and handling information to support experimental use.

  • Prodrug of ralaniten that targets the androgen receptor N-terminal domain.
  • Orally active in preclinical studies.
  • High purity suitable for research applications.
  • Molecular weight 521.00 g/mol; formula C27H33ClO8.
  • Appearance: liquid, colorless to light yellow.
  • Storage conditions provided for pure form and for solutions.
  • For research use only; not for human or veterinary use.

Catalog No. 50-002-38344


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.